MORGAN STANLEY

Holdings History for ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA)

Symbol: ZVRA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$10,374,901	1,157,913	+601,963	+108%	$8.96	Q4 2025
30 Sep 2025	0%	+0%	$5,287,085	555,950	+342,862	+161%	$9.51	Q3 2025
30 Jun 2025	0%	+0%	$1,877,313	213,088	+1,240	+0.59%	$8.81	Q2 2025
31 Mar 2025	0%	-0%	$1,586,742	211,848	-45,375		$7.49	Q1 2025
31 Dec 2024	0%	+0%	$2,145,239	257,223	+129,740	+100%	$8.34	Q4 2024
30 Sep 2024	0%	+0%	$884,732	127,483	+64,844	+100%	$6.94	Q3 2024
30 Jun 2024	0%	-0%	$306,931	62,639	-27,488		$4.90	Q2 2024
31 Mar 2024	0%	+0%	$522,736	90,127	+15,984	+22%	$5.80	Q1 2024
31 Dec 2023	0%	+0%	$485,637	74,143	+46,232	+166%	$6.55	Q4 2023
30 Sep 2023	0%	-0%	$134,531	27,911	-23,539	-46%	$4.82	Q3 2023
30 Jun 2023	0%	+0%	$262,395	51,450	+3,264	+6.8%	$5.10	Q2 2023
31 Mar 2023	0%	+0%	$265,023	48,186	+37,716	+360%	$5.50	Q1 2023
31 Dec 2022	0%	-0%	$48,057	10,470	-7,113	-40%	$4.59	Q4 2022
30 Sep 2022	0%	-0%	$109,000	17,583	-37,810	-68%	$6.20	Q3 2022
30 Jun 2022		0%	$1,000	181	0		$5.52 ^*	Q2 2022
30 Jun 2022	0%	+0%	$247,000	55,393	+41,021	+285%	$4.46	Q2 2022
31 Mar 2022	0%	-0%	$72,000	14,372	-2,002	-12%	$5.01	Q1 2022
31 Dec 2021	0%	-0%	$143,000	16,374	-27,246	-62%	$8.73	Q4 2021
30 Sep 2021	0%	+0%	$407,000	43,620	+22,393	+105%	$9.33	Q3 2021
30 Jun 2021	0%	+0%	$272,000	21,227	+11,134	+110%	$12.81	Q2 2021
31 Mar 2021	0%	+0%	$93,000	10,093	+10,093	NEW	$9.21	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.